Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial mutations in cancer.

M Brandon1, P Baldi, D C Wallace

  • 1Center for Molecular and Mitochondrial Medicine and Genetics (MAMMAG) and Institute for Genomics and Bioinformatics, University of California at Irvine, Irvine, CA 92697-3940, USA.

Oncogene
|August 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Measurement of Neutrino Oscillation Parameters with 10 Years of Data from the NOvA Experiment.

Physical review letters·2026
Same author

Dual-Baseline Search for Active-to-Sterile Neutrino Oscillations in NOvA.

Physical review letters·2025
Same author

Search for CP-Violating Neutrino Nonstandard Interactions with the NOvA Experiment.

Physical review letters·2024
Same author

Intrinsic polarity inversion in III-nitride waveguides for efficient nonlinear interactions.

Optics express·2023
Same author

Measurement of the ν_{e}-Nucleus Charged-Current Double-Differential Cross Section at ⟨E_{ν}⟩=2.4  GeV Using NOvA.

Physical review letters·2023
Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same journal

Correction: Liver-specific SIRT1 knockout-induced hyperglycemia promotes spontaneous lung adenocarcinomas through HSF1-MDM2.

Oncogene·2026
Same journal

Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Oncogene·2026
Same journal

Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitination.

Oncogene·2026
Same journal

DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment.

Oncogene·2026
Same journal

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

Oncogene·2026
See all related articles

Mitochondrial DNA mutations in tumors can either impair energy production, promoting cancer growth, or help tumors adapt to new environments. These findings suggest mitochondrial dysfunction is key to cancer development and may offer new treatment strategies.

Area of Science:

  • Mitochondrial biology
  • Cancer research
  • Genetics

Background:

  • Solid tumors exhibit aerobic glycolysis, producing lactate and suggesting mitochondrial defects.
  • Mitochondria are crucial for cellular energy (OXPHOS), ROS generation, and apoptosis, using both nuclear and mitochondrial DNA (nDNA, mtDNA).
  • mtDNA, essential for OXPHOS, has a high mutation rate; severe mutations cause disease, while some polymorphisms aid environmental adaptation.

Purpose of the Study:

  • To investigate the role of mitochondrial DNA (mtDNA) mutations in cancer etiology.
  • To explore the dual nature of mtDNA mutations in tumor development and adaptation.
  • To identify potential new avenues for cancer diagnosis and treatment based on mitochondrial dysfunction.

Main Methods:

  • Analysis of tumor metabolism, specifically aerobic glycolysis and lactate production.

Related Experiment Videos

  • Review of known mutations in nuclear-encoded mitochondrial genes (e.g., fumarate hydratase, succinate dehydrogenase).
  • Examination of germline and somatic mtDNA mutations, including their prevalence in cancer and the general population.

    • Main Results:

    • Tumor cells utilize OXPHOS-derived ATP to drive glycolysis via induced hexokinase II.
    • Germline mtDNA mutations are linked to breast and endometrial cancers.
    • A significant percentage of tumor-specific somatic mtDNA mutations are also found in the general population, suggesting two classes: severe (inhibiting OXPHOS, promoting proliferation) and mild (aiding adaptation).

    Conclusions:

    • Mitochondrial dysfunction is implicated in cancer etiology.
    • mtDNA mutations in tumors can be severe, promoting proliferation, or mild, facilitating adaptation.
    • Understanding these mtDNA mutations may lead to novel cancer diagnostic and therapeutic strategies.